FASLG and diabetes mellitus: The physiological relevance of FasL+ B cells was assessed in the NOD mouse model of diabetes, where these cells promote apoptosis of diabetogenic T cells in vitro and a reduction of antigen-specific Th1 responses in vivo (468).